ClinicalTrials.Veeva

Menu

Neutrophil Gelatinase-associated Lipocalin as a New Biomarker to Detect Acute Kidney Injury in Postoperative Cardiac Surgery

F

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Status

Unknown

Conditions

Cardiac Surgery

Study type

Observational

Funder types

Other

Identifiers

NCT01594788
IIBSP-NGL-2011-04

Details and patient eligibility

About

Observational study aimed to test the ability of Neutrophil Gelatinase-associated Lipocalin (NGAL) concentration in blood and urine to predict and diagnose early acute renal failure (ARF) in patients after cardiac surgery with/without Cardiopulmonary bypass (CPB).

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Men or women over 18 years proposed for cardiac surgery with / without CPB.
  • Accepting to participate in the study, with informed consent signed by the patient, guardian or family member.

Exclusion criteria

  • Patients < 18 years.
  • Patients do not agree to participate in the study.

Trial contacts and locations

1

Loading...

Central trial contact

Mercedes Garcia, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems